ArticleCancer medicine2017
Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
Article in Cancer medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- ABO blood types can play a role in determining the aggressiveness of thyroid cancer in adult patients: a single-centre retrospective study.BMC endocrine disorders · 2025Article
- Fucosylation in digestive inflammatory diseases and cancers: From mechanical studies to clinical translation.Genes & diseases · 2025Review
- Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overall and by Adjuvant Chemotherapy Regimens.Annals of surgical oncology · 2025Article
- Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas.Langenbeck's archives of surgery · 2024Article
- Common single-base insertions in the VNTR of the carboxyl ester lipase (CEL) gene are benign and also likely to arise somatically in the exocrine pancreas.Human molecular genetics · 2024Article
- Pancreatic Cancer and Detection Methods.Biomedicines · 2023Review
- Pancreatic cancer among solid organ transplant recipients in the United States.Journal of cancer research and clinical oncology · 2023Article
- Erythroprotective Potential of Phycobiliproteins Extracted fromMetabolites · 2023Article
- The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2022Article
- Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer.Medicina (Kaunas, Lithuania) · 2022Review
- Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population.Annals of gastroenterological surgery · 2021Article
- ABO blood group antigen therapy: a potential new strategy against solid tumors.Scientific reports · 2021Article
- Pancreatic cancer: A review of epidemiology, trend, and risk factors.World journal of gastroenterology · 2021Review
- Early Detection of Pancreatic Cancer: Risk Factors and the Current State of Screening Modalities.Gastroenterology & hepatology · 2021Article
- ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.Medicine · 2020Observational
- Pathogenic Carboxyl Ester Lipase (CEL) Variants Interact with the Normal CEL Protein in Pancreatic Cells.Cells · 2020Article
- Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data.Cancer management and research · 2020Article
- Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes.The journal of pathology. Clinical research · 2020Article
- ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.Internal medicine (Tokyo, Japan) · 2020Article
- Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.BMC cancer · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Both serology-based and genetic studies have reported an association between pancreatic cancer risk and ABO blood groups. We have investigated this relationship in a cohort of pancreatic cancer patients from Western Norway (n = 237) and two control materials (healthy blood donors, n = 379; unselected hospitalized patients, n = 6149). When comparing patient and blood donor ABO allele frequencies, we found only the A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.